Theriva Biologics, Inc.
TOVX
Revenue
0.00
0.000.00%
-Assets
42.39M
▼-6.34M▼-13.01%
3 Months ChangeLiabilities
14.74M
▲137.00k▲0.9379%
3 Months ChangeFree Cash Flow
-5.62M
▼-716.00k▼-14.61%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001104659-24-113480
2024-10-16
Form 8-K
ID: 0001104659-24-108958
2024-10-03
Form 8-K
ID: 0001104659-24-105634
2024-09-30
Form 8-K
ID: 0001104659-24-103813
2024-09-23
Form 8-K
ID: 0001104659-24-101892
2024-09-16
Form 8-K
ID: 0001104659-24-100010
2024-09-09
Form 8-K
ID: 0001104659-24-098225
2024-08-26
Form 8-K
ID: 0001104659-24-092644
2024-08-16
Form 8-K
ID: 0001104659-24-090522
2024-08-13
Form 10-Q
ID: 0001410578-24-001342